Zhipeng Wang

Guangdong Academy of Medical Sciences and General Hospital, Shengcheng, Guangdong, China

Are you Zhipeng Wang?

Claim your profile

Publications (2)2.93 Total impact

  • Source
    Jianxing Zhang · Zhipeng Wang · Yan Wang · Guobin Zhou · Hongying Li
    [Show abstract] [Hide abstract]
    ABSTRACT: Some studies have demonstrated dexmedetomidine has anti-inflammatory effect on septic rats. However, the mechanism of how dexmedetomidine exerts these effects is still remained unknown. This study was designed to investigate the mechanism of how dexmedetomidine inhibits the production of inflammatory mediators in cecal ligation and puncturinduced septic rats. 48 Sprague-Dawley rats were randomly divided into six groups: sham-operated (sham) group, cecal ligation and puncture (CLP) group, dexmedetomidine 5 μg/kg (DEX5) group, dexmedetomidine 10 μg/kg (DEX10) group,dexmedetomidine + yohimbine (DEX10 + Yoh) group and yohimibine group (Yoh). Blood, bronchoalveolarlavage fluid (BALF) and lung tissues in each group were collected at six hours after dexmedetomidine or yohimbine treatment,. Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in BALF and plasma were measured by enzyme-linked immunosorbent assay (ELISA). Toll-like receptor-4(TLR4) and myeloid differerntiation factor(MyD88) expression were measuredby quantitative PCR, and extracellular signal-regulated kinase (ERK) 1/2 phosphorylation were determined by western blott. Compared with CLP group, dexmedetomidine significantly decreased not only the production of TNF-α and IL-6 both in plasma and BALF, but also inhibited the expression of TLR4 and MyD88 in mRNA level and the activation of ERK1/2 and NF-κB in the lung tissues of CLP-induced septic rats. All these effects could not be reversed by yohimibine. Dexmedetomidine treatment can effectively reduce the generation of inflammatory mediators in the plasma and BALF of CLP-induced septic rats. These effects of dexmedetomidine rely on TLR4/MyD88/MAPK/ NF-κB signaling pathway and are independent of α2-adrenoceptor.
    BMC Anesthesiology 05/2015; 15(1):68. DOI:10.1186/s12871-015-0042-8 · 1.38 Impact Factor
  • Zhen Li · Guodong Zhao · Guobin Zhou · Yan Wang · Qing Wang · Jinquan Ji · Zhipeng Wang
    [Show abstract] [Hide abstract]
    ABSTRACT: The inflammatory response is a non-specific autoimmune response. Monocytes are the most important effector cells in the systemic inflammatory response. In recent years, the function of the intravenous anesthetic, propofol, in the inhibition of the inflammatory response has attracted much attention. However, the specific signal transduction mechanism related to the anti-inflammatory effect of propofol remains unclear. In this study, monocyte protein expression in rats with endotoxemia was detected using proteomic techniques before and after propofol intervention. By two-dimensional electrophoresis and mass spectrometric identification, we found that S100A9 protein expression was significantly reduced after propofol treatment. In addition, we used western blot analysis to confirm the results of two-dimensional electrophoresis. The S100A9 protein, a member of the S100A calcium-binding protein family, is closely related to the occurrence and development of inflammation. The results of this study suggest that the anti-inflammatory effect of propofol may be related to the inhibition of S100A9 protein expression.
    Molecular Medicine Reports 06/2012; 6(3):657-61. DOI:10.3892/mmr.2012.957 · 1.55 Impact Factor